Where The Selling Ran Deepest: 23 Stocks At 52-Week Lows
A new list of market lows surfaces even as the broader index climbs, raising questions about value and damage.
While the S&P 500 has returned +1.6% over the last month, a different story is unfolding for a select group of companies. On Tuesday, 23 stocks from the Russell 3000 are trading at their 52-week lows. The list includes Summit Therapeutics (SMMT), a company with a market value of about $9.7 billion, and Boost Run (BRUN), which has seen its stock slide 51.2% over the last month.
This raises a critical question for any investor: when does a new low signal a broken company versus a business on sale? The full list of names follows.
The Complete 52-Week-Low List
Here are all 23 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| SMMT | $9.7 Bil | -4.2% | -14.2% | -10.4% | -56.2% |
| MP | $7.3 Bil | -4.3% | -10.8% | -23.4% | -33.5% |
| OKLO | $6.7 Bil | -5.3% | -10.3% | -20.8% | -47.6% |
| PRIM | $4.3 Bil | -7.8% | -10.1% | -15.2% | -14.8% |
| CRK | $3.6 Bil | -4.8% | -6.8% | -13.4% | -40.3% |
| MWH | $2.9 Bil | -9.3% | -10.8% | -29.0% | n/a |
| EMAT | $2.9 Bil | -5.3% | -11.1% | -32.6% | n/a |
| XXI | $2.9 Bil | -2.9% | -10.6% | -17.3% | n/a |
| KLRA | $2.0 Bil | -4.2% | -9.1% | -19.6% | n/a |
| TRLV | $1.6 Bil | 0.0% | -7.0% | -7.3% | n/a |
| TMC | $1.5 Bil | -5.0% | -10.7% | -15.5% | -53.9% |
| BBAI | $1.3 Bil | -2.5% | -6.1% | -20.7% | -62.7% |
| QNT | $1.3 Bil | -5.8% | -15.0% | -34.1% | n/a |
| EOSE | $1.1 Bil | -6.6% | -20.5% | -43.2% | -47.1% |
| BRUN | $0.8 Bil | -13.8% | -34.6% | -51.2% | n/a |
| ARRY | $0.8 Bil | -7.4% | -15.6% | -28.4% | -26.2% |
| KDK | $0.7 Bil | -3.3% | -5.9% | -19.6% | n/a |
| HNRG | $0.7 Bil | -3.9% | -12.0% | -16.7% | -9.8% |
| PSIX | $0.6 Bil | -7.2% | -12.2% | -26.6% | -69.2% |
| GTN-A | $0.6 Bil | -2.7% | -11.9% | -5.6% | -37.2% |
| VTS | $0.6 Bil | -1.6% | -5.7% | -5.0% | -31.9% |
| METC | $0.6 Bil | -4.1% | -17.9% | -22.4% | -56.7% |
| SPRY | $0.6 Bil | -1.6% | -10.8% | -33.6% | -68.3% |
Is a falling stock price always a sign of a shrinking business?
The data suggests otherwise. Consider MP Materials (MP), the second-largest company on today’s list with a market value of about $7.3 billion. While its stock has declined 23.4% over the last month, its revenue grew 17.7% over the last twelve months.
Similarly, Comstock Resources (CRK) saw its revenue grow 39.9% over the last twelve months, and it now trades at 5.6 times trailing earnings.
A new low is a signal to check the fundamentals, not the ticker.
A list of stocks at their weakest price of the last year is not an automatic shopping list. A 52-week low can mark a business with genuine operational damage, or it can represent a temporarily marked-down asset.
The disciplined move is to treat the price as a signal to investigate the business itself. The real work begins after the screen, not before it.
A 52-week-low list tells you where the pain is; it does not tell you which of these declines are worth buying. That second question is what our Buy the Dip screen answers, every day: beaten-down names where the fundamentals still hold up.
A 52 Week Low Is A Stress Test For Concentrated Portfolios
Every stock on this list just showed its holders what a bad year feels like. How much damage any single position could do to your net worth is a question with a precise answer. The Trefis Wealth team computes it for investors professionally, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.